Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Valcyte (valganciclovir HCl) Tablets, 450 mg, Hoffman-La Roche NDA 21-304/S1 9/12/03 9/25/03 9/25/03 Valcyte (valganciclovir HCl) Tablets, 450 mg, Roche Global Development-Palo NDA 21-304 3/29/01 4/13/01 4/13/01 Valcyte Indications: Treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). | Valganciclovir Hydrochloride Tablets, Ranbaxy, Inc., Tentative Approval | Valcyte (valganciclovir hydrochloride) Oral Solution, Hoffmann-La Roche, Inc., Approval | Valcyte (valganciclovir hydrochloride) Tablets, Hoffmann-La Roche Inc., Efficacy Supplement and Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com